MANNINO RAPHAEL J 4
4 · Matinas BioPharma Holdings, Inc. · Filed Jan 3, 2020
Insider Transaction Report
Form 4
MANNINO RAPHAEL J
Chief Scientific Officer
Transactions
- Other
Common Stock, par value $0.0001 per share
2019-06-21+2,000→ 1,426,565 total - Award
Stock option (right to buy)
2020-01-01+100,000→ 100,000 totalExercise: $2.27Exp: 2030-01-01→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Stock dividend, payable to all holders of records of Series B Preferred Stock of 200 shares of Common Stock for each share of Series B Preferred Stock.
- [F2]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on January 1, 2021 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2021.